MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617083107 A) filed by Denali Therapeutics Inc. on July 06, 2026, for Fusion Proteins Comprising Acid Alpha-Glucosidase Enzymes And Methods Thereof.
Inventors include Kariolis, Mihalis S.; Lenser, Melina; Mahon, Cathal S.; Ngo, Hanh Giai; Rajendra, Yashas; Tyagi, Shrishti; and Yuan, Tianao.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Provided herein are proteins, which are capable of being transported across the blood- brain barrier (BBB) and comprise an acid alpha-glucosidase (GAA) enzyme-Fc fusion polypeptide. Certain embodiments also provide methods of using such proteins to treat Pompe disease.
Disclaimer: Curated by HT Syndication.
